Labiotech.eu

News and Trends 22 Jun 2020

Epidarex Capital Targets UK Biotech with €112M Venture Fund

The transatlantic life science VC Epidarex Capital has closed its third fund at a value of €112.7M, which will be used to build new biotech companies from emerging hubs across the UK. The ‘Epidarex Capital III UK LP’ fund is based on a €55.2M (£50M) commitment from the British Business Bank. The remainder comes from […]

June 22, 2020 - 2 minutesmins - By Laura Cowen

News and Trends 22 Jun 2020

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

A new class of drug developed by the Swedish biotech company Affibody has proved better at treating symptoms of psoriasis than a placebo in a phase II trial, leading the company to develop the candidate for other conditions such as uveitis and psoriatic arthritis. The phase II study enlisted 108 patients with psoriasis, a chronic […]

June 22, 2020 - 3 minutesmins - By David Wilson

In Depth 22 Jun 2020

The Age of Agrochemicals is Ending: It’s Time for Agricultural Biotechnology

As Europe moves to reduce its reliance on agrochemicals in the farming system over the next 10 years and beyond, a crucial question emerges: what replaces them? Agricultural biotechnology could provide the answer. The use of agrochemicals — pesticides, fertilizers, and plant growth enhancers — has been crucial to humanity over the last century. They’ve […]

June 22, 2020 - 9 minutesmins - By Farhan Mitha

pharmamar jazz pharmaceuticals lung cancer

News and Trends 19 Jun 2020

Cancer Drug Inspired by Sea Animal Gets FDA Green Light

The Spanish company PharmaMar’s stock price has shot up by 30% as its cancer drug lurbinectedin was given accelerated approval for the second-line treatment of metastatic small cell lung cancer in the US this week. Lurbinectedin will be marketed under the brand name Zepzelca and will be made commercially available in the US in early […]

June 19, 2020 - 3 minutesmins - By Manuela Callari

News and Trends 18 Jun 2020

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

Belgian biotech eTheRNA has secured €34M in Series B funding to progress to the clinic its Covid-19 vaccine candidate and cancer immunotherapies made from messenger RNA. The company’s five existing investors contributed to the round, including Dutch VC firm LSP, and the Boehringer Ingelheim Venture Fund, based in Germany. Four new investors also contributed — […]

June 18, 2020 - 3 minutesmins - By Helen Albert

tumor cancer immunotherapy alderaan biotech

News and Trends 17 Jun 2020

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

A Series A round closed by Barcelona-based startup Ona Therapeutics will finance the preclinical development of a drug that prevents cancer from spreading in the body by targeting the metabolism of cancer cells. The round was supported by returning investor Asabys Partners, as well as new European investors including Alta Life Sciences, Bpifrance, Fund+, and […]

June 17, 2020 - 2 minutesmins - By Victor Kotsev

universal cancer vaccine mrna biontech personalized medicine

News and Trends 17 Jun 2020

German Government Invests €300M in mRNA Biotech CureVac

The Federal Republic of Germany will invest €300M in CureVac, the homegrown biotech that is developing a vaccine for Covid-19 using messenger RNA technology. The unusually large investment will be made through the state-owned bank Kreditanstalt für Wiederaufbau, which will gain a 23% stake in the company. “CureVac retains complete operational and strategic independence,” Franz-Werner […]

June 17, 2020 - 4 minutesmins - By Helen Albert

In Depth 17 Jun 2020

How is European Biotech Rising to the Covid-19 Testing Challenge?

Diagnostics have been thrown into the spotlight in the Covid-19 pandemic because of their instrumental role in preventing further infections. However, developing a test for Covid-19 isn’t an easy task. What exactly is needed to make a good Covid-19 test, and how are European biotech companies working to fill this need? While the development of […]

June 17, 2020 - 10 minutesmins - By Mark Livingstone

News and Trends 16 Jun 2020

UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck

UK biotech startup Bit Bio has received €36.9M in Series A funding to boost the manufacturing efficiency of human cells for use in cell therapy and drug discovery. The impressive deal brings Bit Bio’s total funding to €44.4M since it was spun off from the University of Cambridge in 2016. It’s the second-largest Series A […]

June 16, 2020 - 3 minutesmins - By External Contributor

News and Trends 15 Jun 2020

Chilean Biotech Moves to France to Develop Anti-Mold Food Preservative

The startup Protera is moving from Santiago de Chile to Paris following a €5M Series A round that will let the company scale up the production of an antifungal protein food preservative to the pilot scale. The Series A round was led by the European venture capital firm Sofinnova Partners, and will allow the company […]

June 15, 2020 - 4 minutesmins - By David Kirk

News and Trends 15 Jun 2020

Novo Nordisk Foundation Commits €100M Grant to Developing Green Tech

The Novo Nordisk Foundation has awarded a five-year grant of €100M to the DTU Biosustain research center near Copenhagen to support the development of sustainable green technology. DTU Biosustain was founded in 2011 and forms part of the Danish Technical University. The Novo Nordisk Foundation, which is one of the largest charitable foundations in the […]

June 15, 2020 - 3 minutesmins - By Helen Albert

In Depth 15 Jun 2020

Drug Development in Covid-19 Times: Is Going Remote the Answer?

With the coronavirus pandemic forcing scientific research labs to close around the globe, it seems almost inevitable that the ongoing crisis will accelerate the growing demand for remote drug development. A number of European companies see this as an opportunity to introduce computer-aided biology and robot-driven labs. In recent years, the pharmaceutical industry has been […]

June 15, 2020 - 7 minutesmins - By David Cox

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Epidarex Capital Targets UK Biotech with €112M Venture Fund

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

The Age of Agrochemicals is Ending: It’s Time for Agricultural Biotechnology

Cancer Drug Inspired by Sea Animal Gets FDA Green Light

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

German Government Invests €300M in mRNA Biotech CureVac

How is European Biotech Rising to the Covid-19 Testing Challenge?

UK Startup Bags €37M to Remove Cell Therapy Manufacturing Bottleneck

Chilean Biotech Moves to France to Develop Anti-Mold Food Preservative

Novo Nordisk Foundation Commits €100M Grant to Developing Green Tech

Drug Development in Covid-19 Times: Is Going Remote the Answer?

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!